LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.98 | 27.76 | 117 | 941 | 0.1243 | 0.3271 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.98 | 27.76 | 1144 | 941 | 1.2155 | 1.0783 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.98 | 27.76 | 1 | 941 | 0.0011 | -0.4799 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.98 | 27.76 | 1248 | 941 | 1.3260 | 1.1142 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 20.68 | 27.76 | 205 | 1119 | 0.1832 | 0.4549 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 20.68 | 27.76 | 1281 | 1119 | 1.1448 | 1.0514 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 20.68 | 27.76 | 3 | 1119 | 0.0027 | -0.3411 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 20.68 | 27.76 | 1388 | 1119 | 1.2404 | 1.0824 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 22.39 | 27.76 | 539 | 1305 | 0.4128 | 0.7056 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 22.39 | 27.76 | 1365 | 1305 | 1.0454 | 1.0160 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 22.39 | 27.76 | 7 | 1305 | 0.0054 | -0.2196 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 22.39 | 27.76 | 1490 | 1305 | 1.1411 | 1.0481 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.09 | 27.76 | 648 | 1461 | 0.4433 | 0.7348 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.09 | 27.76 | 1443 | 1461 | 0.9873 | 0.9955 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.09 | 27.76 | 7 | 1461 | 0.0048 | -0.2141 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.09 | 27.76 | 1589 | 1461 | 1.0871 | 1.0294 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 25.79 | 27.76 | 830 | 1605 | 0.5171 | 0.7869 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 25.79 | 27.76 | 1560 | 1605 | 0.9719 | 0.9903 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 25.79 | 27.76 | 11 | 1605 | 0.0069 | -0.1463 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 25.79 | 27.76 | 1759 | 1605 | 1.0959 | 1.0315 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.49 | 27.76 | 980 | 1723 | 0.5687 | 0.8192 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.49 | 27.76 | 1597 | 1723 | 0.9268 | 0.9746 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.49 | 27.76 | 16 | 1723 | 0.0093 | -0.0884 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.49 | 27.76 | 1864 | 1723 | 1.0817 | 1.0266 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 29.19 | 27.76 | 1154 | 1863 | 0.6194 | 0.8482 | MN20160318_Q01 | F04 |